SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Hospitalised COVID-19 patients suffer symptoms for months
Tues October 20th - Many hospitalised COVID-19 patients were still experiencing symptoms of breathlessness, fatigue, anxiety and depression up to three months after contracting the virus, according to a new study. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Breakthrough brings hearing treatment hope

Thursday September 13th, 2012

British scientists have made a breakthrough in the search for new treatments for hearing loss, it was announced last night.

The researchers at Sheffield University have successfully used stem cells to generate new cells in laboratory studies.

The research involved gerbils and showed improvements that emerged about four weeks after treatment.

The scientists say the treatment seemed to cut hearing loss by nearly one half.

They used embryonic stem cells which they had converted to neurons, which connect the ear to the brained.

The treatment, reported in the journal Nature, is aimed at a hearing loss condition called auditory neuropathy, which involves the cochlear cells, which connect hair cells, which detect sound, to the brain.

Some patients might get the treatment together with well-established cochlear implant devices, which connect the outside world directly to cochlear cells.

Researcher Dr Marcelo Rivolta said: "We believe this an important step forward. We have now a method to produce human cochlear sensory cells that we could use to develop new drugs and treatments, and to study the function of genes.

"And more importantly, we have the proof-of-concept that human stem cells could be used to repair the damaged ear."

He added: "More research is needed. For instance, we want to understand the long term implications of this treatment and its safety."

Dr Ralph Holme, of Action on Hearing Loss, which has backed the scientists, said: “The research we have funded at the University of Sheffield is tremendously encouraging and gives us real hope that it will be possible to fix the actual cause of some types of hearing loss in the future.

"For the millions of people for whom hearing loss is eroding their quality of life, this can’t come soon enough."

Nature September 12 2012

Tags: Hearing | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES